Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 GeneticVariation phenotype BEFREE Antero-dorso-medial stimulation site in the STA were associated with less tremor and adverse effects in our small single-center cohort of ET patients with thalamic DBS. 30981663 2019
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE OBJECTIVEPosterior subthalamic area (PSA) deep brain stimulation (DBS) targeting the zona incerta (ZI) is an emerging treatment for tremor syndromes, including Parkinson's disease (PD) and essential tremor (ET). 30875687 2019
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE Indeed, PSA is a promising target for DBS for intractable proximal and distal tremor, even in cases of previous, suboptimal functional neurosurgery. 31600751 2019
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE We also propose possible pathophysiological explanations for the phenomenon and define a nomenclature of the associated features: early versus late DBS failure; tremor rebound versus habituation (to be preferred over tolerance). 31433906 2019
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE This study provides Class IV evidence that for patients with tremor with thalamic DBS, acute short pulse stimulation reduces adverse effects, while directional steering does not provide a generalizable benefit regarding adverse effects. 30045955 2018
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE To evaluate whether unilateral DBS targeting the caudal zona incerta (cZi) may be sufficient to alleviate voice tremor in patients with essential tremor, or whether bilateral stimulation is needed. 29975951 2018
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE Whilst changes in the frequency of subthalamic deep brain stimulation (STN-DBS) have been proposed to improve control of tremor or axial motor features in Parkinson's disease (PD), little is known about the effects of frequency changes on upper limb motor function, particularly bradykinesia. 29614696 2018
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE Direct targeting of the dentato-rubro-thalamic tract is efficacious in DBS for tremor suppression. 30187527 2018
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE Magnetic resonance-guided focused ultrasound thalamotomy is cost-effective for tremor compared with DBS and stereotactic radiosurgery and more effective than both. 28370272 2017
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.100 Biomarker phenotype BEFREE Bilateral subthalamic nucleus DBS holds the most promising results for patients with tremor, severe motor fluctuations and dyskinesias from L-dopa, with the best improvements seen in daily activities and quality of life. 12869808 2003